Breast Cancer Therapy Market Size (2024 – 2030)

The Global Breast Cancer Therapy Market was valued at USD 9 billion in 2023 and is projected to reach a market size of USD 16.56 billion by the end of 2030. Over the forecast period of 2024-2030, the market is projected to grow at a CAGR of 9.1%.

In the past, there were very less treatment options for treating breast cancer, and many of them did not showcase survival rates. However, with time, new therapies were developed such as chemotherapy and advanced surgical procedures (mastectomy and lumpectomy). Further, recent years witnessed a technological diffusion in the healthcare sector, which includes the use of AI, digital imaging techniques, advancements in biomarkers and targeted therapies, and others. Moreover, the future for the breast cancer therapy market holds positive, as with the rising telemedicine trends in major regions of the world such as Asia-Pacific, North America, and Europe, there are further product developments and innovations in treatment strategies.

Key Market Insights:

According to Breast Cancer Org, Breast cancer is the most commonly diagnosed cancer in the USA and each year 30% of newly diagnosed cancers are breast cancer.

Moreover, as per a study published in Pubmed, breast cancer in India accounts for 29.2%, and 216,108 cases were estimated in the year 2022.

AI integration has enhanced the productivity of various healthcare treatments. Moreover, research and development are taking place in the healthcare sector that can help prevent the disease from spreading in the body. In May 2023, a research unit at King’s College London developed an AI model that helps to predict the development of secondary breast cancer. Moreover, an expert from the college found that the AI model can assess and predict the lymph nodes of those with triple-negative breast cancer. Further, 5000 lymph nodes were studied using the AI model.

Breast Cancer Therapy Market Drivers:

The increasing incidences of breast cancer have contributed to the growth of breast cancer treatment in the market.

Breast cancer is amongst the most common and threatening cancers globally, and approximately millions of women are affected by it each year. This is evident by the statistics provided by the Breast Cancer Org, that, breast cancer contributes to 12.5% of all new annual cancer cases worldwide among women, and nearly 30% of newly diagnosed cancers are breast cancers in women. Moreover, one of the most common causes of breast cancer is aging, and hence, women over 40 are more prone to it than other age groups. In addition, hereditary and sedentary lifestyles are other common reasons that cause breast cancer among women. These factors have increased the demand for treatment and therapies of breast cancer in the market, which includes early detection and screening of breast cancer (mammography) and the use of technologically advanced screening techniques such as the use of 3D mammograms, breast ultrasound, and others. Furthermore, gene identification testing techniques enable healthcare professionals to assess the mutation in genes such as BRCA1 and BRCA2 and implement preventive measures accordingly. All these factors have propelled the market demand for breast cancer treatment.

Advancements in clinical research and development have driven the growth of the Breast Cancer Therapy Market.

The healthcare sector has witnessed increased productivity due to the infusion of technology in many therapies and treatments. Moreover, continuous research efforts by clinical experts have evolved new therapies that are more personalized and effective in nature. These include precision medicine for breast cancer, wherein the blood sample or tumor tissue is collected for assessing the cancer level and type, which further aids healthcare professionals devise effective treatment strategies. Furthermore, new marvels are shaping the market for breast cancer treatment, which includes the research and development of breast cancer vaccines, targeted therapies such as inhibitors, and AI integration in breast cancer prediction are some of the advancements in the breast cancer treatment field. Additionally, less toxic chemotherapy options are being developed by researchers and experts that can help to mitigate breast cancer. Furthermore, advancements in lumpectomy such as remote incision lumpectomies that help in hiding scars from surgery and the use of electromagnetic waves in lumpectomy surgeries that make sure all the cancer cells are removed accurately, are other developments paving the way towards the increased demand for breast cancer treatment in the market.

Breast Cancer Therapy Market Restraints & Challenges:

Misinformation and lack of education are hampering the market growth of breast cancer treatment in the market.

There is a lack of education and misconception about breast cancer treatments affecting negatively or leading to failure post-surgery. Moreover, in remote and less developed regions women are unaware of the symptoms, early detection, treatment, and remedies for breast cancer, which can hamper the growth of breast cancer treatment in the market.

The high cost of treatment can affect the market demand for breast cancer treatment.

Breast cancer treatments are conducted in phases and many of the therapies such as targeted therapies, immunotherapies, chemotherapy, drug testing, and screening, and others utilize advanced equipment and technology, which leads to an increase in the overall cost of the treatment and hence poses a financial burden on the patients.

Breast Cancer Therapy Market Opportunities:

One of the key factors contributing to the development of breast cancer treatment is the growing trends in telemedicine. Telemedicine can improve the treatment process of patients and help reduce delays pre and post surgeries. This can further help patients in remote areas who are not able to take the benefits of healthcare centers directly. Further, the development of digital monitoring tools by healthcare companies can help doctors and other healthcare professionals track the progress of cancer treatment, assess the medicinal benefits, and predict the recovery time of patients. In addition, rising demand for personalized treatment is driving the market potential for personalized medicines, such as biomarkers. In addition, the infusion of AI in imaging technologies can further boost the productivity of breast cancer detection and screening in the healthcare market.

BREAST CANCER THERAPY MARKET REPORT COVERAGE:

Breast Cancer Therapy Market Segmentation: By Treatment

• Surgery

• Hormonal

• Chemotherapy

• Targeted Therapy

• Immunotherapy

• Biosimilars

• Others

Based on market segmentation by treatment, chemotherapy occupied the highest share of about 25.1% in the market in the year 2023. Chemotherapy has been there in the treatment of cancer for a very long time and has witnessed various developments that aim to improve the quality of life of people. Moreover, chemotherapy helps in destroying, curing, and preventing cancer from returning the cells. Further, it also helps in shrinking the tumor before surgery and can relieve a patient from the risks of cancer. Furthermore, continuous efforts in the R&D field have evolved the treatment landscape and led to the development of chemotherapy drugs, targeted or precision delivery systems in the treatment and others. Furthermore, there is an increasing trend towards combination chemotherapy due to its accurate targeting and rapid elimination of cancer cells from the body.

The targeted therapy segment is the fastest-growing segment during the forecast period. Targeted therapy is an advancement in the Breast Cancer Therapy Market that focuses on the elimination of cancer cells by targeting specific molecules inside the body. These include HER-2 targeted therapies, PI3K inhibitors, and others. Moreover, the rising demand for precision medicine by patients has increased the demand for targeted therapies, as they have showcased more cases of improvement and survival among women and have helped in the early detection and reduction of incidences of genetic mutations, such as BRCA 1 and BRCA 2 genetic mutation.

Breast Cancer Therapy Market Segmentation: By Cancer Type

• Hormone Receptor-Positive Breast Cancer

• HER2-Positive Breast Cancer

• Triple Negative Breast Cancer

• Triple Positive Breast Cancer

• Inflammatory Breast Cancer

• Others

Based on market segmentation by cancer type, hormone receptor-positive breast cancer occupied the highest share of about 29% in the market in the year 2023. This type of cancer accounts for major cases of breast cancer incidences among women. As per studies, about 70 to 80% of newly diagnosed cancers account for hormone receptor cancer in women. Moreover, this type of cancer has receptors for estrogen and binds to specific hormones for the cancer cells to grow. Further, it necessitates the need to test the presence of hormone receptor cancer, as it helps healthcare professionals devise proper hormonal therapy and medicines for the patients.

Triple-negative breast cancer is the fastest-growing segment during the forecast period. This type of cancer is diagnosed when the cancer cells test negative for estrogen levels and are more aggressive than any other type. According to the American Cancer Society, triple-negative breast cancer contributes to 10-15% of breast cancers. Moreover, such increasing prevalence of triple-negative breast cancer among women has increased the demand for targeted therapies and combination therapies to reduce its impact.

Breast Cancer Therapy Market Segmentation: By Distribution Channel

• Retail Pharmacies

• Hospital Pharmacies

• Online Pharmacies

• Others

Based on market segmentation by distribution channel, retail pharmacies occupied the highest share of about 23% in the market in the year 2023. Retail pharmacies have been witnessing an increase in demand from consumers due to the affordability and easy availability of medicines & supportive care products they offer. Moreover, this distribution channel offers increased convenience to local areas, where there is limited access to healthcare services.

Hospital pharmacies occupy the second position in the market. Hospital pharmacies offer access to precise and complex medicines, as well as healthcare devices for breast cancer treatment, which increases the efficiency of the treatment process. Moreover, they facilitate easy access, as they are situated inside the healthcare facilities, which reduces the hassle for the patients and their visitors to search for medications outside the vicinity.

The online pharmacy segment has been gaining traction in recent years and is the fastest-growing segment during the forecast period. They have facilitated access to medicines and other supportive healthcare products from the comfort of home with facilities such as same-day delivery, access to pharmacists, chemists, and doctor’s expertise, a wide selection of products along with their benefits, and others. The growing demand for telemedicine is one of the major reasons for the growth of online pharmacies in the market.

Breast Cancer Therapy Market Segmentation:  Regional Analysis

• North America

• Asia-Pacific

• Europe

• South America

• Middle East and Africa

Based on market segmentation by region, North America occupied the highest share of about 27% in the market in 2023. North America witnesses a high prevalence of breast cancer among women, which has contributed to the growth of breast cancer treatment in the market. As per the American Cancer Society, in the USA, approximately 310, 720 new cases have been diagnosed with invasive breast cancer in women. Furthermore, a sedentary lifestyle due to a fast-paced working environment, genetic mutation such as BRCA1 among women, intoxication of substances along rising obesity have been the prime reasons for breast cancers in the region. Moreover, this has led to continuous research and development in treatment strategies in the region, such as the development of drugs that can be used with or after hormonal therapy, targeted therapies, AI imaging techniques, and others.

Asia-Pacific is the fastest-growing segment during the forecast period. The rising elderly population in the region along with increased government support in the form of expenditure allocation to the healthcare sector, and emerging health-tech start-ups in the region have contributed to the growth of the Breast Cancer Therapy Market in the region.

COVID-19 Impact Analysis on the Global Breast Cancer Therapy Market:

The pandemic had a mixed impact on the Breast Cancer Therapy Market. The pandemic affected the treatment time in healthcare centers, due to shifted focus towards treating patients affected by the pandemic. Moreover, patients' visits for screening & detection witnessed a decline, however, there was an increased growth in telemedicine, which enabled patients to consult healthcare professionals in the comfort of their homes through digital devices such as laptops and smartphones. Moreover, there was an increase in research and development for chronic diseases, and breast cancer accounted for one of them. However, there was a delay in the rapid implementation of clinical trials and research due to the shifted focus towards the virus.

Latest Trends & Developments:

The market for breast cancer treatment has witnessed various developments and is further developing innovative treatment strategies for curing patients. For instance, there is a rise of technologically advanced devices for imaging, screening, and early detection, which include 3D mammography, AI-based imaging systems, AI-based monitoring systems, and computational biomarkers that help in measuring the live progress of disease and the effects of treatment on the patient’s body. In addition, the development of new drugs that help in the speedy treatment of breast cancer has provided new opportunities for healthcare manufacturers. For instance, researchers in the American Society for Clinical Oncology announced the positive results in the annual meet of 2023, of a phase-2 clinical trial of HER3-DXd, which is an antibody-drug for targeting HER3 patients with metastatic breast cancers. During the trial, 35% of patients responded positively to the drug. Furthermore, advancements in immunotherapies such as targeting non-cancer cells that can help prevent the growth and spread of breast cancer in the body, and many other advancements are contributing to the growth of breast cancer treatment in the market.

Key Players

1. AstraZeneca Plc

2. F. Hoffman-La Roche Ltd

3. Amgen

4. Novartis AG

5. Pfizer

6. Eli Lilly and Company

7. Macrogenics, Inc

8. Gilead Sciences Inc

9. Eisai Co., Ltd

10. Daiichi Sankyo Company

In May 2022, Roche Pharma launched a drug for treating breast cancer. The drug is combined with two monoclonal antibodies that can be delivered by a single injection and help in reducing the treatment delay by 90%.